Monte Rosa grants inducement awards to new hires, including options priced at $14.31
GLUE•Inducement awards granted to new hires
Monte Rosa Therapeutics granted inducement equity awards to six newly hired non-executive employees under its 2026 Inducement Plan.
Awards include stock options for 31,145 shares with an exercise price of $14.31, based on the Sept. 1 Nasdaq close.
The options vest 25% after one year, then in 36 monthly installments, subject to continued service.
Restricted stock units cover 6,440 shares, vesting 25% on each of the first four anniversaries.
